Vigilare Wealth Management Heron Therapeutics, Inc. Transaction History

Vigilare Wealth Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 20, 2020	SELL	$10.89 - $21.47 $307,043 - $605,346	-28,195 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$10.23 - $24.56 $83,067 - $199,427	8,120 Added 40.45%	28,195 $331,000
Q4 2019 Feb 13, 2020	BUY	$17.42 - $26.61 $349,706 - $534,195	20,075 New	20,075 $418,000

168

119M

151K

103K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $341M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.